| Home > For doctors > Protocols > Cardiovascular > Hypertension |
![]() |
Hypertension: BHS guidelines 2004 |
|
|||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* In heart failure when used as monotherapy.
Angiotensin converting enzyme inhibitors or angiotensin II receptor
blockers may be beneficial in chronic renal failure but should only be
used with caution, close supervision, and specialist advice when there
is established and significant renal impairment.
Caution with angiotensin converting enzyme inhibitors and angiotensin II
receptor blockers in peripheral vascular disease because of association
with renovascular disease.
Angiotensin converting enzyme inhibitors and angiotensin II receptor
blockers are sometimes used in patients with renovascular disease under
specialist supervision.
¶ In combination with a thiazide or thiazide-like diuretic.
**
blockers are used increasingly to treat stable heart failure but may
worsen heart failure.
![]()
Thiazides or thiazide-like diuretics may sometimes be necessary to
control blood pressure in people with a history of gout, ideally used in
combination with allopurinol.
Primary prevention
Secondary prevention (including patients with type 2 diabetes)
Derived from:
|
|
British Hypertension Society guideline 2004 (BMJ summary) |
|
|
British Hypertension Society |
British Hypertension Society guidelines
2004: